Search results
Results from the WOW.Com Content Network
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Wave Life Sciences wasn’t one of them. The 10 stocks that made ...
For most of fiscal year 2024, Life Sciences company valuations remained higher than pre-COVID levels but declined after the U.S. elections. Looking ahead to fiscal year 2025, initial forecasts and ...
Galena Biopharma, Inc. (originally RXi Pharmaceuticals) was a publicly traded pharmaceutical company based in San Ramon, California. The company was founded in Worcester, Massachusetts. In 2011, it moved to Oregon, [1] [2] and in 2015 moved to San Ramon, California. [3] Mark Schwartz was the company's president and chief executive officer.
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, [1] especially in relation to approaches making use of new cell therapy or gene therapy developments. [2]
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
For premium support please call: 800-290-4726 more ways to reach us
These business groups provide fluid management products and systems to customers in biotechnology, pharmaceutical, transfusion medicine, energy, electronics, municipal and industrial water purification, aerospace, transportation and broad industrial markets. The company was founded by David B. Pall in 1946 as Micro Metallic Corporation. [12]
The latter will focus exclusively on their life science division. [12] In August 2022, Azenta Life Sciences has come to a definitive agreement to acquire B Medical Systems S.á.r.l., in a transaction of approx. €410 million (with an additional €50 million in future performance milestones) is expected to be completed by October 2022. [13]